Diebold (DBD) Misses Q4 EPS by 5c; Cuts FY EPS Outlook
Get Alerts DBD Hot Sheet
Price: $67.08 -2.32%
Financial Fact:
Total cost of sales: 424.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Total cost of sales: 424.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold (NYSE: DBD) reported Q4 EPS of $0.48, $0.05 worse than the analyst estimate of $0.53. Revenue for the quarter came in at $861.27 million versus the consensus estimate of $869.9 million.
Diebold sees FY2015 EPS of $1.80-$2.00, versus prior guidance of $1.90-$2.10 and the consensus of $2.02.
For earnings history and earnings-related data on Diebold (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance
- BMO Capital Starts Lululemon (LULU) at Underperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share